Alice Park

Park is a senior health correspondent at TIME. She covers the COVID-19 pandemic, new drug developments in cancer and Alzheimer’s disease, mental health, HIV, CRISPR, and advances in gene therapy, among other issues in health and science. She also covers the Olympics and co-chaired TIME’s inaugural TIME 100 Health Summit in 2019. Her work has won awards from the New York Press Club and recognition from the Deadline Club. In addition, she is the author of The Stem Cell Hope: How Stem Cell Medicine Can Change Our Lives. Follow her on Instagram at @aliceparktime.

Recent Articles

A New Immune Treatment for Cancer

Several types of cancer appear to respond to an immune-based treatment.

By Alice Park

How a New Weight-Loss Pill Could Transform Health

The first truly revolutionary oral drug for obesity, made by Eli Lilly, may soon be on the way

By Alice Park

Robert F. Kennedy Jr.

For years, Robert F. Kennedy Jr. has raised questions about vaccine safety. Now, as the Secretary of Health and Human Services, Kennedy oversees the government’s key health agencies, including the Centers for Disease Control and...

By Alice Park

Tomas Cihlar and Wesley Sundquist: 2025 TIME100

Find out why Tomas Cihlar and Wesley Sundquist are one of the 100 most influential people of 2025.

By Alice Park

Peter Marks on an Anti-Vaccine FDA

Dr. Peter Marks, an ex-FDA vaccine official, is warning of a fundamental change at the agency—where vaccine skepticism now prevails.

By Alice Park

Invasive Strep Infections Are Rising

Serious strep cases—which can result in flesh-eating infections—are increasing in the U.S.

By Alice Park

Medicare Won't Cover Weight-Loss Drugs

The decision counters a proposal by the Biden Administration to reimburse beneficiaries for the weight-loss medications.

By Alice Park

Gavi CEO Makes the Case for U.S. Funding

'This is about potentially a million children dying if funding is withdrawn,' says Dr. Sania Nishtar, CEO of Gavi, the Vaccine Alliance.

By Alice Park

A Blood Test for Alzheimer’s Disease?

The test, which is not yet commercially available, focuses on a different form of the protein tau.

By Alice Park

Scientists Perform Pig Liver Transplant

The surgery tested the idea of whether a pig liver might supplement the function of a failing liver for patients waiting for a transplant.

By Alice Park

There's a New Pill to Treat UTIs

Blujepa is the first new antibiotic for the condition in 30 years.

By Alice Park

Dr. Francis Collins on the Future of Science

"Medical research institutions across the country are in crisis."

By Alice Park

Weight-Loss Drugs Linked to Hair Loss

It’s the latest side effect associated with the popular medications.

By Alice Park

A Pill to Prevent COVID-19?

Results from a late-stage study on the new drug ensitrelvir are encouraging.

By Alice Park

What to Know About Dr. Mehmet Oz

One of the world's most famous doctors and TV personalities could soon run the U.S. Centers for Medicare and Medicaid Services.

By Alice Park

The Scientific Search for Youth

Scientists are working to figure out how to delay the negative effects of aging at a cellular level.

By Alice Park

What to Know About Jay Bhattacharya

Trump's pick to head the National Institutes of Health has been famously critical of the U.S. COVID-19 response.

By Alice Park

RFK Jr. Cites Measles Vaccine Amid Worsening Outbreak

However, he also mentions vitamin A for U.S. measles patients—a therapy experts doubt.

By Alice Park

FDA Cancels a Meeting to Decide the Next Flu Shot

The group meets every year to discuss the best vaccine for the upcoming flu season. Until now.

By Alice Park

The Latest on the Health of Pope Francis

Experts say his battle underscores the risk of respiratory infections in older people.

By Alice Park
More from TIME
More From TIME